Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktoria Konya

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Immunology Letters|July 12, 2016
Lipid mediators as regulators of human ILC2 function in allergic diseasesViktoria Konya, Jenny Mjösberg
Methods in Molecular Biology (Clifton, N.J.)|July 3, 2014
Adhesion of eosinophils to endothelial cells or substrates under flow conditionsViktoria Konya, Miriam Peinhaupt, Akos Heinemann
Pharmacology & Therapeutics|March 26, 2013
E-type prostanoid receptor 4 (EP4) in disease and therapyViktoria Konya, Gunther Marsche, Rufina Schuligoi, et al.
Journal of Leukocyte Biology|May 19, 2011
Inhibitory effect of prostaglandin I2 on bone marrow kinetics of eosinophils in the guinea pigEva M Sturm, Rufina Schuligoi, Viktoria Konya, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Aging affects high-density lipoprotein composition and functionMichael Holzer, Markus Trieb, Viktoria Konya, et al.
Histochemistry and Cell Biology|February 2, 2012
Differential response of arterial and venous endothelial cells to extracellular matrix is modulated by oxygenLuciana Lassance, Heidi Miedl, Viktoria Konya, et al.
Nature Immunology|February 16, 2016
The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencingÅsa K Björklund, Marianne Forkel, Simone Picelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formationSonia Philipose, Viktoria Konya, Ivana Sreckovic, et al.
Vascular Pharmacology|September 25, 2016
The EP1/EP3 receptor agonist 17-pt-PGE<sub>2</sub> acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammationAnna Theiler, Viktoria Konya, Lisa Pasterk, et al.
Experimental Dermatology|March 18, 2011
Photohardening restores the impaired neutrophil responsiveness to chemoattractants leukotriene B4 and formyl-methionyl-leucyl-phenylalanin in patients with polymorphic light eruptionAlexandra Gruber-Wackernagel, Akos Heinemann, Viktoria Konya, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Immunology Letters|July 12, 2016
Lipid mediators as regulators of human ILC2 function in allergic diseasesViktoria Konya, Jenny Mjösberg
Methods in Molecular Biology (Clifton, N.J.)|July 3, 2014
Adhesion of eosinophils to endothelial cells or substrates under flow conditionsViktoria Konya, Miriam Peinhaupt, Akos Heinemann
Pharmacology & Therapeutics|March 26, 2013
E-type prostanoid receptor 4 (EP4) in disease and therapyViktoria Konya, Gunther Marsche, Rufina Schuligoi, et al.
Journal of Leukocyte Biology|May 19, 2011
Inhibitory effect of prostaglandin I2 on bone marrow kinetics of eosinophils in the guinea pigEva M Sturm, Rufina Schuligoi, Viktoria Konya, et al.
Biochimica Et Biophysica Acta|June 25, 2013
Aging affects high-density lipoprotein composition and functionMichael Holzer, Markus Trieb, Viktoria Konya, et al.
Histochemistry and Cell Biology|February 2, 2012
Differential response of arterial and venous endothelial cells to extracellular matrix is modulated by oxygenLuciana Lassance, Heidi Miedl, Viktoria Konya, et al.
Nature Immunology|February 16, 2016
The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencingÅsa K Björklund, Marianne Forkel, Simone Picelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formationSonia Philipose, Viktoria Konya, Ivana Sreckovic, et al.
Vascular Pharmacology|September 25, 2016
The EP1/EP3 receptor agonist 17-pt-PGE<sub>2</sub> acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammationAnna Theiler, Viktoria Konya, Lisa Pasterk, et al.
Experimental Dermatology|March 18, 2011
Photohardening restores the impaired neutrophil responsiveness to chemoattractants leukotriene B4 and formyl-methionyl-leucyl-phenylalanin in patients with polymorphic light eruptionAlexandra Gruber-Wackernagel, Akos Heinemann, Viktoria Konya, et al.
Pageof 4